Analyst Consensus ?
ConsensusBuy18 ratings
Bullish1372.2%
Neutral527.8%
Bearish00.0%
FN2 Earnings Intelligence
CDW Corporation (CDW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 23, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | May 27, 2026 |
| UBS | Buy | Buy | Maintain | May 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| Raymond James | Strong Buy | Outperform | Upgrade | Nov 25, 2025 |
| Stifel | Buy | Buy | Maintain | Jul 17, 2024 |
| Northcoast Research | Buy | Neutral | Upgrade | Jun 7, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2023 |
| B of A Securities | Neutral | Buy | Downgrade | Apr 19, 2023 |
| CFRA | Hold | Hold | Maintain | May 7, 2020 |
| Bank of America | Buy | Buy | Maintain | Jul 30, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Apr 17, 2019 |
| Baird | Outperform | Neutral | Upgrade | May 9, 2017 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 4, 2016 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 1, 2015 |
| RBC Capital | Outperform | Outperform | Maintain | May 8, 2015 |
Upside is calculated against the persisted previous close $145.56. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Erik Woodring | $170 | $123.57 | +16.8% | Jun 23, 2026 |
| RBC Capital | Analyst unavailable | $130 | $108.59 | -10.7% | May 27, 2026 |
| UBS | Analyst unavailable | $147 | $113.08 | +1.0% | May 7, 2026 |
| Barclays | Analyst unavailable | $123 | $109 | -15.5% | May 7, 2026 |
| Raymond James | Analyst unavailable | $150 | $111.17 | +3.1% | May 6, 2026 |
| UBS | Analyst unavailable | $162 | $138.08 | +11.3% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $144 | $138.08 | -1.1% | Feb 5, 2026 |
| Evercore ISI | Analyst unavailable | $180 | $127.51 | +23.7% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $141 | $131.75 | -3.1% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $177 | $145.02 | +21.6% | Dec 17, 2025 |
| Raymond James | Adam Tindle | $185 | $141.92 | +27.1% | Nov 25, 2025 |
| UBS | Analyst unavailable | $190 | $142.21 | +30.5% | Nov 5, 2025 |
| Barclays | Analyst unavailable | $148 | $141.66 | +1.7% | Nov 5, 2025 |
| Citigroup | Asiya Merchant | $245 | $226.3 | +68.3% | Oct 1, 2024 |
| Northcoast Research | Keith Housum | $270 | $224.24 | +85.5% | Jun 7, 2024 |
| J.P. Morgan | Analyst unavailable | $225 | $178.46 | +54.6% | Dec 20, 2022 |
| Stifel Nicolaus | Matthew Sheerin | $210 | $171.68 | +44.3% | Apr 18, 2022 |
| Morgan Stanley | Erik Woodring | $214 | $178.83 | +47.0% | Apr 4, 2022 |
Track every rating change on CDW the moment it posts. Free to start.
Start free